SEC Comment Letter 0000000000-25-002661 to Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc.
Date: March 11, 2025 · CIK: 0001707502 · Accession: 0000000000-25-002661
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285611
Letter
Re: Solid Biosciences Inc. Registration Statement on Form S-3 Filed March 6, 2025 File No. 333-285611 Dear Alexander Cumbo:
March 11, 2025
Alexander Cumbo Chief Executive Officer Solid Biosciences Inc. 500 Rutherford Avenue, Third Floor Charlestown, MA 02129
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Caroline Dotolo, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> March 11, 2025 Alexander Cumbo Chief Executive Officer Solid Biosciences Inc. 500 Rutherford Avenue, Third Floor Charlestown, MA 02129 Re: Solid Biosciences Inc. Registration Statement on Form S-3 Filed March 6, 2025 File No. 333-285611 Dear Alexander Cumbo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Caroline Dotolo, Esq. </TEXT> </DOCUMENT>